Business Description
Kuros Biosciences Ltd
ISIN : CH0325814116
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 6.47 | |||||
Equity-to-Asset | 0.79 | |||||
Debt-to-Equity | 0.04 | |||||
Debt-to-EBITDA | -0.21 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 9.55 | |||||
Beneish M-Score | -2.04 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 76.8 | |||||
3-Year EBITDA Growth Rate | 6.9 | |||||
3-Year EPS without NRI Growth Rate | 6.8 | |||||
3-Year FCF Growth Rate | 13.6 | |||||
3-Year Book Growth Rate | -15.8 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 35.44 | |||||
9-Day RSI | 43.08 | |||||
14-Day RSI | 48.26 | |||||
6-1 Month Momentum % | 123.51 | |||||
12-1 Month Momentum % | 327.86 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.06 | |||||
Quick Ratio | 1.69 | |||||
Cash Ratio | 1.05 | |||||
Days Inventory | 156.89 | |||||
Days Sales Outstanding | 48.54 | |||||
Days Payable | 47.88 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -3.9 | |||||
Shareholder Yield % | -0.23 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 71.32 | |||||
Operating Margin % | -39.3 | |||||
Net Margin % | -40.9 | |||||
FCF Margin % | -27.32 | |||||
ROE % | -21.73 | |||||
ROA % | -17.7 | |||||
ROIC % | -22.47 | |||||
ROC (Joel Greenblatt) % | -482.8 | |||||
ROCE % | -20.26 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 7.14 | |||||
PB Ratio | 4.23 | |||||
Price-to-Tangible-Book | 15.19 | |||||
EV-to-EBIT | -17.4 | |||||
EV-to-EBITDA | -22.01 | |||||
EV-to-Revenue | 6.82 | |||||
EV-to-FCF | -26.31 | |||||
Price-to-Median-PS-Value | 0.55 | |||||
Price-to-Net-Current-Asset-Value | 19.21 | |||||
Earnings Yield (Greenblatt) % | -5.74 | |||||
FCF Yield % | -3.8 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Kuros Biosciences Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil CHF) | 33.564 | ||
EPS (TTM) (CHF) | -0.38 | ||
Beta | 1.03 | ||
Volatility % | 93.51 | ||
14-Day RSI | 48.26 | ||
14-Day ATR (CHF) | 0.564572 | ||
20-Day SMA (CHF) | 7.018 | ||
12-1 Month Momentum % | 327.86 | ||
52-Week Range (CHF) | 1.25 - 8.4 | ||
Shares Outstanding (Mil) | 36.88 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Kuros Biosciences Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Kuros Biosciences Ltd Stock Events
Event | Date | Price(CHF) | ||
---|---|---|---|---|
No Event Data |
Kuros Biosciences Ltd Frequently Asked Questions
What is Kuros Biosciences Ltd(XSWX:KURN)'s stock price today?
When is next earnings date of Kuros Biosciences Ltd(XSWX:KURN)?
Does Kuros Biosciences Ltd(XSWX:KURN) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |